Orthofix Medical (OFIX) Non-Current Assets (2010 - 2026)
Orthofix Medical's (OFIX) quarterly Non-Current Assets came in at $425.1 million in Q1 2026, down 1.79% YoY from $432.8 million in Q1 2025, and down 2.01% on a QoQ basis from $433.8 million in Q4 2025.
Orthofix Medical (OFIX) Non-Current Assets (2010 - 2026) Analysis & Trends
Orthofix Medical (OFIX) has 17 years of Non-Current Assets data on file, last reported at $425.1 million in Q1 2026.
- Quarterly Non-Current Assets fell 1.79% year-over-year to $425.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 7.05% YoY) and the FY2025 annual result came in at $433.8 million, down 5.7% from the prior year.
- Non-Current Assets slipped to $425.1 million in Q1 2026, from $433.8 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $512.0 million in Q3 2023 to a low of $202.6 million in Q4 2022.
- A 5-year average of $409.5 million and a median of $441.3 million in 2025 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets retreated 17.42% — and 2023, when it jumped 152.49%.
- Tracing OFIX's Non-Current Assets over 5 years: stood at $202.6 million in 2022, then surged by 149.15% to $504.9 million in 2023, then fell by 8.89% to $460.0 million in 2024, then declined by 5.7% to $433.8 million in 2025, then fell by 2.01% to $425.1 million in 2026.
- The last three Non-Current Assets figures came in at $425.1 million (Q1 2026), $433.8 million (Q4 2025), and $438.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Orthofix Medical | 410.49 Mn | 306.09 Mn | 149.71 Mn | 426.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 426.89 Mn |
| Mar 31, 2026 | 425.08 Mn |
| Dec 31, 2025 | 433.80 Mn |
| Sep 30, 2025 | 438.44 Mn |
| Jun 30, 2025 | 441.33 Mn |
| Mar 31, 2025 | 432.83 Mn |
| Dec 31, 2024 | 460.01 Mn |
| Sep 30, 2024 | 481.66 Mn |
| Jun 30, 2024 | 495.93 Mn |
| Mar 31, 2024 | 507.07 Mn |
| Dec 31, 2023 | 504.87 Mn |
| Sep 30, 2023 | 511.96 Mn |
| Jun 30, 2023 | 501.94 Mn |
| Mar 31, 2023 | 507.10 Mn |
| Dec 31, 2022 | 202.64 Mn |
| Sep 30, 2022 | 202.77 Mn |
| Jun 30, 2022 | 206.46 Mn |
| Mar 31, 2022 | 206.89 Mn |
| Dec 31, 2021 | 207.10 Mn |
| Sep 30, 2021 | 240.18 Mn |